An Israeli biotech company claims it is on the verge of human trials for a breakthrough drug that could extend human lifespan by up to 30 percent. Tel Aviv-based Sirtlab is developing a treatment that targets the age-regulating protein SIRT-6, which the company says also enhances brain function, organ health, and overall vitality.
